263 related articles for article (PubMed ID: 32501632)
1. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
[TBL] [Abstract][Full Text] [Related]
2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
3. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
[TBL] [Abstract][Full Text] [Related]
4. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.
Jun L; Zhenlin Y; Renyan G; Yizhou W; Xuying W; Feng X; Yong X; Kui W; Jian L; Dong W; Hongyang W; Lehua S; Mengchao W; Feng S
Oncologist; 2012; 17(7):963-9. PubMed ID: 22653882
[TBL] [Abstract][Full Text] [Related]
5. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
[TBL] [Abstract][Full Text] [Related]
6. Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.
Yu JJ; Xiao W; Dong SL; Liang HF; Zhang ZW; Zhang BX; Huang ZY; Chen YF; Zhang WG; Luo HP; Chen Q; Chen XP
BMC Cancer; 2018 Aug; 18(1):835. PubMed ID: 30126375
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
Hu B; Yang XR; Xu Y; Sun YF; Sun C; Guo W; Zhang X; Wang WM; Qiu SJ; Zhou J; Fan J
Clin Cancer Res; 2014 Dec; 20(23):6212-22. PubMed ID: 25271081
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.
Wei HW; Qin SL; Xu JX; Huang YY; Chen YY; Ma L; Qi LN
Cancer Med; 2023 Jul; 12(14):15065-15078. PubMed ID: 37337754
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
10. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
11. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
12. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma.
Zhou KQ; Sun YF; Cheng JW; Du M; Ji Y; Wang PX; Hu B; Guo W; Gao Y; Yin Y; Huang JF; Zhou J; Fan J; Yang XR
EBioMedicine; 2020 Dec; 62():103107. PubMed ID: 33181461
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
[No Abstract] [Full Text] [Related]
14. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
[TBL] [Abstract][Full Text] [Related]
15. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
16. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
17. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.
Wang Z; Luo L; Cheng Y; He G; Peng B; Gao Y; Jiang ZS; Pan M
J Gastrointest Surg; 2018 Apr; 22(4):633-639. PubMed ID: 29159757
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status.
Qi LN; Ma L; Chen YY; Chen ZS; Zhong JH; Gong WF; Lu Y; Xiang BD; Li LQ
Ann Med; 2020; 52(1-2):21-31. PubMed ID: 31876201
[No Abstract] [Full Text] [Related]
20. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.
Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS
PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
